pemoline and Hepatic Failure studies

pemoline and Hepatic Failure

pemoline has been researched along with Hepatic Failure in 3 studies

Pemoline: A central nervous system stimulant used in fatigue and depressive states and to treat hyperkinetic disorders in children.
pemoline : A member of the class of 1,3-oxazoles that is 1,3-oxazol-4(5H)-one which is substituted by an amino group at position 2 and by a phenyl group at position 5. A central nervous system stimulant, it was used to treat hyperactivity disorders in children, but withdrawn from use following reports of serious hepatotoxicity.

Research Excerpts

Excerpt	Relevance	Reference
"Pemoline is a central nervous system (CNS) stimulant approved for use as part of the comprehensive medical management of attention deficit hyperactivity disorder (ADHD)."	6.40	Pemoline-associated hepatic failure: a critical analysis of the literature. ( Schreiber, R; Shevell, M, 1997)
"Pemoline is a central nervous system (CNS) stimulant approved for use as part of the comprehensive medical management of attention deficit hyperactivity disorder (ADHD)."	2.40	Pemoline-associated hepatic failure: a critical analysis of the literature. ( Schreiber, R; Shevell, M, 1997)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

1 (33.33)

18.2507

2000's

2 (66.67)

29.6817

2010's

0 (0.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Shader, RI	1
Shevell, M	1
Schreiber, R	1
Hogan, V	1

Studies

Shader, RI

Shevell, M

Schreiber, R

Hogan, V

Reviews

1 review available for pemoline and Hepatic Failure

Article	Year
Pemoline-associated hepatic failure: a critical analysis of the literature. Pediatric neurology, 1997, Volume: 16, Issue:1 Topics: Adverse Drug Reaction Reporting Systems; Attention Deficit Disorder with Hyperactivity; Central Nerv	1997

Article

Year

Pemoline-associated hepatic failure: a critical analysis of the literature.

Pediatric neurology, 1997, Volume: 16, Issue:1

Topics: Adverse Drug Reaction Reporting Systems; Attention Deficit Disorder with Hyperactivity; Central Nerv

1997

Other Studies

2 other studies available for pemoline and Hepatic Failure

Article	Year
Drug-attributed hepatic failure: causality, risk assessment, consent, and confusion. Journal of clinical psychopharmacology, 2003, Volume: 23, Issue:6 Topics: Central Nervous System Stimulants; Confusion; Humans; Informed Consent; Liver Failure; Patients; Pem	2003
Pemoline (Cylert): market withdrawal. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2000, Jan-11, Volume: 162, Issue:1 Topics: Adverse Drug Reaction Reporting Systems; Attention Deficit Disorder with Hyperactivity; Canada; Cent	2000

Article

Year

Drug-attributed hepatic failure: causality, risk assessment, consent, and confusion.

Journal of clinical psychopharmacology, 2003, Volume: 23, Issue:6

Topics: Central Nervous System Stimulants; Confusion; Humans; Informed Consent; Liver Failure; Patients; Pem

2003

Pemoline (Cylert): market withdrawal.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2000, Jan-11, Volume: 162, Issue:1

Topics: Adverse Drug Reaction Reporting Systems; Attention Deficit Disorder with Hyperactivity; Canada; Cent

2000